Insiders · Profile

Aromando Andrew

Chief Business Officer at ONCOLYTICS BIOTECH. Filing since 11 Feb 2026. CIK 0001976455

Company
Date
Role
Action
Shares
Amount
Of holding
11 Feb 2026
Chief Business Officer
Bought
29,600
$25.42K
116%
1 decision on file.